Gallery
Company Bio
Newcells builds functionally relevant in vitro models of organs that accurately predict in vivo outcomes.
Using its expertise in induced pluripotent stem cells, cellular physiology and organoid technology, Newcells engineers models of kidney, retina, liver and lung from patient samples as well as from a range of preclinical species. These are used in studies of drug efficacy and toxicity either as a service for pharma and biotech clients or as products supplied for use by research teams developing new drugs.
